A Comparison of Point-of-Care Instruments Designed for Monitoring Oral Anticoagulation with Standard Laboratory Methods

Our study compared point-of-care (POC) device monitoring with traditional clinical laboratory methods device of patients on oral anticoagulant therapy. The POC devices used in the study were Coumatrak, CoaguChek, CoaguChek Plus, Thrombolytic Assessment System (TAS) PT-One, TAS PTNC, TAS PT, Hemachron Jr. Signature, ProTime Microcoagulation System, and Medtronics ACT II. The clinical laboratory method used thromboplastins with different ISI values: Innovin and Thromboplastin C Plus (TPC). All POC INRs showed strong correlation with both laboratory methods, with correlation coefficients of >0.900. All POC methods demonstrated a significant (p <0.05) difference in INR values, except the TAS PTNC and ACT II INRs (p: 0.12 and 0.71 respectively) when compared with Innovin INRs. All POC INRs were significantly different from TPC generated INRs (p <0.05). Comparisons of the POC INRs to the group mean of the POC methods, show higher correlation (R>0.93), but there were still significant (p<0.05) differences noted between the POC group INR mean and CoaguChek Plus, ACT II, TAS PT-One, TAS PTNC, and Hemachron Jr Signature INRs. These data indicate that POC INR biases exist between laboratory methods and POC devices. Until a suitable whole blood INR standardization method is available, we conclude that clinicians using point-of-care anticoagulation monitoring should be aware of differences between POC and parent laboratory values.

[1]  J. Hirsh,et al.  Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. , 2001, Chest.

[2]  J. Jespersen,et al.  Correction for lack of coincidence of normal and abnormal calibration slopes in ISI determination. , 1999, Thrombosis and haemostasis.

[3]  S. Kitchen,et al.  Local Calibration of International Normalised Ratio Improves between Laboratory Agreement: Results from the UK National External Quality Assessment Scheme , 1999, Thrombosis and Haemostasis.

[4]  J. Jespersen,et al.  The European Concerted Action on Anticoagulation (ECAA): Field Studies of Coagulometer Effects on the ISI of ECAA Thromboplastins , 1998, Thrombosis and Haemostasis.

[5]  P. Mannucci,et al.  Collaborative Study for the Calibration of a Proposed Reference Preparation for Thromboplastin , Human Recombinant , Plain On behalf of the Subcommittee on Control of Anticoagulation , 2017 .

[6]  Monitoring oral anticoagulant therapy with point-of-care devices: correlations and caveats. , 1997, Clinical chemistry.

[7]  P. Mannucci,et al.  Determination of the International Sensitivity Index of a New Near-Patient Testing Device to Monitor Oral Anticoagulant Therapy , 1997, Thrombosis and Haemostasis.

[8]  Vittorio Pengo,et al.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.

[9]  V. Marzinotto,et al.  Home monitoring of warfarin therapy in children with a whole blood prothrombin time monitor. , 1995, The Journal of pediatrics.

[10]  S. Olson,et al.  Failure to Generate Comparable International Normalized Ratio Values Using Five Different Thromboplastin Reagents in Parallel Studies of Patients Receiving Warfarin , 1995 .

[11]  T. Andrews,et al.  Complications of warfarin therapy monitored by the international normalized ratio versus the prothrombin time ratio , 1995, Clinical cardiology.

[12]  C. Ts'ao,et al.  Implications of use of low international sensitivity index thromboplastins in prothrombin time testing. , 1994, Archives of pathology & laboratory medicine.

[13]  W. Williams,et al.  Heparin Therapy during Cardiopulmonary Bypass in Children Requires Ongoing Quality Control , 1993, Thrombosis and Haemostasis.

[14]  S. Pauker,et al.  Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. , 1993, The New England journal of medicine.

[15]  K. High,et al.  Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzer. , 1993, Archives of pathology & laboratory medicine.

[16]  M. Sakon,et al.  Bedside monitoring of warfarin therapy by a whole blood capillary coagulation monitor. , 1992, Thrombosis research.

[17]  S. McCurdy,et al.  Accuracy and precision of a portable anticoagulation monitor in a clinical setting. , 1992, Archives of internal medicine.

[18]  B. Oberhardt,et al.  Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. , 1991, Clinical chemistry.

[19]  L. Poller.  INR--calibration of the therapeutic range. , 1987, Advances in experimental medicine and biology.